Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fradet

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
European Urology|December 9, 2000
p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?B J Schmitz-Dräger, P J Goebell, T Ebert, et al.
The Journal of Urology|November 24, 1999
Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failureF Meyer, L Moore, I Bairati, et al.
The Journal of Urology|May 1, 1996
Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancerB Tetu, Y Fradet, P Allard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1995
[Ipsilateral adrenalectomy in the surgical treatment of renal carcinoma]C Marois, G Bedard, R Charrois, et al.
Urology|August 15, 2001
Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancerF Meyer, I Bairati, C Bédard, et al.
International Journal of Cancer|April 18, 2001
Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomyL Lacombe, A Maillette, F Meyer, et al.
The Journal of Urology|August 1, 1992
Radioimmunodetection of human bladder tumor xenografts in nude mice with radiolabeled monoclonal antibodiesY Fradet, J Friede, B Guertin, et al.
International Journal of Oncology|May 14, 2011
Ha-ras codon 12 mutation in papillary tumors of the urinary-bladder - a retrospective studyA Ooi, F Herz, S Ii, et al.
Oncogene|February 15, 2001
Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interestM Simoneau, H LaRue, T O Aboulkassim, et al.
The American Journal of Pathology|February 1, 1992
Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumorsC Cordon-Cardo, D D Wartinger, M R Melamed, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
European Urology|December 9, 2000
p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?B J Schmitz-Dräger, P J Goebell, T Ebert, et al.
The Journal of Urology|November 24, 1999
Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failureF Meyer, L Moore, I Bairati, et al.
The Journal of Urology|May 1, 1996
Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancerB Tetu, Y Fradet, P Allard, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 1, 1995
[Ipsilateral adrenalectomy in the surgical treatment of renal carcinoma]C Marois, G Bedard, R Charrois, et al.
Urology|August 15, 2001
Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancerF Meyer, I Bairati, C Bédard, et al.
International Journal of Cancer|April 18, 2001
Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomyL Lacombe, A Maillette, F Meyer, et al.
The Journal of Urology|August 1, 1992
Radioimmunodetection of human bladder tumor xenografts in nude mice with radiolabeled monoclonal antibodiesY Fradet, J Friede, B Guertin, et al.
International Journal of Oncology|May 14, 2011
Ha-ras codon 12 mutation in papillary tumors of the urinary-bladder - a retrospective studyA Ooi, F Herz, S Ii, et al.
Oncogene|February 15, 2001
Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interestM Simoneau, H LaRue, T O Aboulkassim, et al.
The American Journal of Pathology|February 1, 1992
Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumorsC Cordon-Cardo, D D Wartinger, M R Melamed, et al.
Pageof 11